These results suggested that dysregulation of LH in PCOS patients had no adverse effect on follicle maturation and ovulation and that combined usage of HMG with letrozole reversed the poor ovarian response, which may be correlated with the abnormally elevated LH followed by letrozole treatment. The gene discussed is PLOD1; the disease is polycystic ovary syndrome.